HEAL Share Price Performance
CA$0.10
0.00 (0.00%)
Price CA$0.10
Share PriceCA$0.10
HEAL Community Narratives
There are no narratives available yet.
Recent HEAL News & Updates
No updates
Restart Life Sciences Corp. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.012
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Restart Life Sciences Corp. Competitors
About HEAL
- Founded
- 2004
- Employees
- n/a
- CEO
- WebsiteView website
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Canadian Market Performance
- 7 Days: 1.3%
- 3 Months: 7.2%
- 1 Year: 20.6%
- Year to Date: 10.0%
The market is up 1.3% over the last week, with the Materials sector leading the way, up 7.4%. In the last year, the market has climbed 21%. Earnings are forecast to grow by 11% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading